-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Dataset
EGAD00001007938
-
Embryonal Rhabdomyosarcoma sequencing data
Dataset
EGAD00001007939
-
Cancer and germline exomes consisting of FASTQ reads from melanoma, lung and colon cancer samples
Dataset
EGAD00001007950
-
Cancer RNA-seq consisting of FASTQ paired-end reads from melanoma and lung cancer sample
Dataset
EGAD00001007951
-
Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells
Dataset
EGAD00001007958
-
EPICC: Evolutionary Predictions in Colorectal Cancer
Dataset
EGAD00001008140
-
Immune profiling reveals enrichment of distinct immune signatures in oral epithelial dysplasia
Dataset
EGAD00001007970
-
Human liver mtDNA sequencing
Dataset
EGAD00001007991
-
Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells
Dataset
EGAD00001007997
-
RBtargetedSeq
Dataset
EGAD00001008004